C-kit gene mutation in human gastrointestinal stromal tumors.
Ying-Yong Hou,Yun-Shan Tan,Meng-Hong Sun,Yong-Kun Wei,Jian-Fang Xu,Shao-Hua Lu,Su-Jie A-Ke-Su,Yan-Nan Zhou,Feng Gao,Ai-Hua Zheng,Tai-Ming Zhang,Wen-Zhong Hou,Jian Wang,Xiang Du,Xiong-Zeng Zhu
DOI: https://doi.org/10.3748/wjg.v10.i9.1310
IF: 5.374
2004-01-01
World Journal of Gastroenterology
Abstract:AIM:To investigate the significance of c-kit gene mutation in gastrointestinal stromal tumors (GIST).
METHODS:Fifty two cases of GIST and 28 cases of other tumors were examined. DNA samples were extracted from paraffin sections and fresh blocks. Exons 11, 9 and 13 of the c-kit gene were amplified by PCR and sequenced.
RESULTS:Mutations of exon 11 were found in 14 of 25 malignant GISTs (56%), mutations of exon 11 of the c-kit gene were revealed in 2 of 19 borderline GISTs (10.5%), and no mutation was found in benign tumors. The mutation rate showed significant difference (chi2=14.39, P<0.01) between malignant and benign GISTs. Most of mutations consisted of the in-frame deletion or replication from 3 to 48 bp in heterozygous and homozygous fashions, None of the mutations disrupted the downstream reading frame of the gene. Point mutations and frame deletions were most frequently observed at codons 550-560, but duplications were most concentrated at codons 570-585. No mutations of exons 9 and 13 were revealed in GISTs, Neither c-kit gene expression nor gene mutations were found in 3 leiomyomas, 8 leiomyosarcomas, 2 schwannomas, 2 malignant peripheral nerve sheath tumors, 2 intra-abdominal fibromatoses, 2 malignant fibrous histiocytomas and 9 adenocarcinomas.
CONCLUSION:C-kit gene mutations occur preferentially in malignant GISTs and might be a clinically useful adjunct marker in the evaluation of GISTs and can help to differentiate GISTs from other mesenchymal tumors of gastrointestinal tract, such as smooth muscle tumors, schwannomas, etc.